Home
Conditions
Multiple Myeloma and Plasma Cell Neoplasm

Clinical trial condition

Multiple Myeloma and Plasma Cell Neoplasm

Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.

214 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma and Plasma Cell Neoplasm trial results

Completed

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

NCT00248430

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00003116

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +53 more
Locations: Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma

NCT00004072

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

MetroHealth Medical Center Cleveland, Ohio, United States

View Trial Details

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Mt. Sinai Medical Center New York, United States

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Oregon Health Sciences University Portland, Oregon, United States

View Trial Details

Completed

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

NCT00410657

Conditions: Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

NCT00096096

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +76 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

NCT00255710

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

NCT00003082

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Multiple Myeloma and Plasma Cell Neoplasm

Multiple Myeloma and Plasma Cell Neoplasm trial results

Related conditions